Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 14:S1600-6135(25)03050-3.
doi: 10.1016/j.ajt.2025.10.005. Online ahead of print.

Beyond theory and into practice: A qualitative study of the experiences of xenotransplant recipients

Affiliations

Beyond theory and into practice: A qualitative study of the experiences of xenotransplant recipients

Macey L Levan et al. Am J Transplant. .

Abstract

With the US Food and Drug Administration clearance of clinical trials of kidney xenotransplantation (XTx) in living humans, understanding the recipient experience is critical. Semistructured interviews with the 3 living XTx recipients identified core domains of the recipient's experience, including quality of life (QoL), fears about XTx, and health care team communication and support. Transcribed interviews were analyzed by 2 qualitative researchers using an inductive thematic approach and were mapped onto the Warwick Patient Experience Model, a validated framework to assess key aspects of patient satisfaction with the health care experience. All 3 recipients (a 53-year-old female, a 66-year-old male, and a 54-year-old male) described a restoration of hope, contrasted with their poor QoL on dialysis. They emphasized that access to XTx and graft survival requires confidence and commitment between recipients and health care teams. XTx recipients use dialysis as a point of reference when describing changes in their posttransplant QoL and seem well-situated to handle the possibility of graft failure. These insights may aid in the creation of decision aids and educational materials tailored to the specific needs of XTx recipients.

Keywords: domains of experience; patient experience; qualitative research; quality of life; xenotransplantation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. M. L. Levan reports consulting from Takeda and Patients Like Me. J. Locke is the Vice President of Medical Development for Xenotransplantation at United Therapeutics. D. Segev reports consulting in the past 36 months from AstraZeneca, Sanofi, Caredx, Regeneron, Novavax, WebMD, Springer, Optum, National Kidney Foundation, Moderna, Medscape, Hansa, Roche, American Society of Nephrology, and Springer. pment; and research grants from Choironex, Lung Biotechnologies (United Therapeutics), and Hansa Biopharma. B. Parent served as a patient advocate for one of the interview subjects. A. Griesemer reports research support from United Therapeutics and ChioroneX. L.V. Riella received research support from eGenesis. R. A. Montgomery reports Advisory Board service for eGenesis, Sanofi, Regeneron, Care Dx, ProCure On Demand, and Hansa Biopharma; consulting for Recombinetics. Hansa Medical, Regeneron, ThermoFisher Scientific, Genentech, Care Dx, One Lambda, ITB Med, Sanofi, and PPD Develo

LinkOut - more resources